Commentary: The WTO’s Parenting Skills Need Improvement
The views expressed here are solely those of the author and do not necessarily represent the views of…
Freight Transportation Stakeholders Grapple With Big Uncertainties
Stakeholders participating in today’s global supply chain must grapple with three big themes: the growing impact of e-commerce,…
Uber Freight Taps Amazon Alum Christenson To Run Europe
In his first 24 hours on the job, the new head of Uber Freight Europe spoke about his…
A Peek Into The Markets: US Stock Futures Climb Ahead Of Earnings
Pre-open movers U.S. stock futures traded higher in early pre-market trade, ahead of earnings from Abbott Laboratories (NYSE:ABT)…
Mitsubishi Motors’ Shares Fall Following Raids By German Authorities
Mitsubishi Motors (OTC:MMTOF) shares fell sharply after authorities raided facilities associated with the company’s German subsidiary on Tuesday over…
Japan, Canada, Europe Central Banks Group Up To Discuss Launching Digital Currencies
The central banks of Japan, Canada, and some of the European Union members are teaming up to study…
EC Approves Roche’s Polivy for People with Previously Treated Aggressive Lymphoma
Roche (OTC:RHHBY) today announced that the European Commission has granted conditional marketing authorisation for Polivy® (polatuzumab vedotin), in…
Novartis Announces EU Approval of Mayzent for Adult Patients with Secondary Progressive MS with Active Disease
Novartis (NYSE:NVS) today announced the European Commission (EC) has approved Mayzent® (siponimod) for the treatment of adult patients…
Jazz Pharmaceuticals Receives EU Marketing Authorisation for Sunosi for Excessive Daytime Sleepiness in Adults with Narcolepsy or Obstructive Sleep Apnea
Jazz Pharmaceuticals plc (NASDAQ:JAZZ) today announced that the European Commission approved Sunosi® (solriamfetol) to improve wakefulness and reduce…
Genmab Announces EU Marketing Authorization for DARZALEX in Combination with Bortezomib, Thalidomide and Dexamethasone in Frontline Multiple Myeloma
Genmab A/S (NASDAQ:GMAB) announced today that the European Commission (EC) has granted marketing authorization for DARZALEX® (daratumumab) in…